Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

SONN
Sonnet BioTherapeutics Holdings, Inc. Common Stock
stock NASDAQ

At Close
May 9, 2025 3:57:14 PM EDT
1.28USD-0.775%(-0.01)21,420
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 9, 2025 8:00:30 AM EDT
1.29USD0.000%(0.00)1,671
After-hours
Dec 31, 1969 7:00:00 PM EST
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 20, 2021
08:34AM EST  Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $2.5   Benzinga
Dec 17, 2021
07:54AM EST  The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx   Benzinga
06:32AM EST  Sonnet BioTherapeutics Files 10-K   Benzinga
Dec 16, 2021
10:14AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021   Benzinga
08:20AM EST  HC Wainwright & Co. Initiates Coverage On Sonnet BioTherapeutics with Buy Rating, Announces Price Target of $2   Benzinga
Oct 18, 2021
06:44AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 06.30 A.M. EDT).   RTTNews
Oct 7, 2021
04:56PM EDT  Sonnet BioTherapeutics Says Received Letter From Listing Qualifications Staff Of Nasdaq Stock Market   Benzinga
Oct 4, 2021
05:21AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.00 A.M. EDT).   RTTNews
Sep 15, 2021
10:05AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021   Benzinga
07:28AM EDT  BTIG Initiates Coverage On Sonnet BioTherapeutics with Buy Rating, Announces Price Target of $5   Benzinga
06:43AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 6.10 A.M. EDT).   RTTNews
Aug 31, 2021
02:26PM EDT  Mid-Afternoon Market Update: Spok Holdings Surges On Takeover Offer; Sequential Brands Shares Slide   Benzinga
12:13PM EDT  Mid-Day Market Update: Zoom Shares Drop After Q2 Results; AC Immune Shares Surge   Benzinga
09:57AM EDT  Why Sonnet BioTherapeutics Stock Is Trading Higher Today   Benzinga
08:15AM EDT  The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical   Benzinga
06:15AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 6.00 A.M. EDT).   RTTNews
05:45AM EDT  Sonnet Biotherapeutics Shares Trading Up 50% Premarket; Company Announced on Monday Successful Completion of the Discovery Phase for Its Next Preclinical Pipeline Candidate SON-1410   Benzinga
Aug 30, 2021
04:02PM EDT  Sonnet Announces Completion Of Discovery Phase For Its Next Preclinical Pipeline Candidate (SON-1410)   Benzinga
Aug 25, 2021
07:30AM EDT  The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug   Benzinga
Aug 20, 2021
02:42PM EDT  Mid-Afternoon Market Update: Crude Oil Down Over 2%; GeoVax Labs Shares Spike Higher   Benzinga
12:12PM EDT  Mid-Day Market Update: Nasdaq Rises 1%; HEXO Shares Plummet   Benzinga
06:40AM EDT  Sonnet BioTherapeutics Late Thursday Priced 35.29M Share Offering Of Common Stock, Warrants At $0.85/Unit   Benzinga
06:03AM EDT  Pre-market Movers: GOVX, PROG, SONN, MRIN,   RTTNews
Aug 19, 2021
06:01AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 5.30 A.M. EDT).   RTTNews
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 16, 2021
06:36AM EDT  Sonnet BioTherapeutics Q3 EPS $(0.27) Up From $(0.44) YoY, Has $6M Cash on Hand   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Jul 27, 2021
11:13AM EDT  The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts   Benzinga
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jul 9, 2021
07:36AM EDT  The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO   Benzinga
Jul 8, 2021
07:45AM EDT  The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test   Benzinga
Jun 14, 2021
07:46AM EDT  Sonnet BioTherapeutics Announces Change in Date of Annual Meeting To Jul. 15   Benzinga
Jun 9, 2021
09:14AM EDT  The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US   Benzinga
Jun 8, 2021
04:31PM EDT  Sonnet BioTherapeutics Announces Issuance Of US Patent For Platform Technology   Benzinga
May 14, 2021
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 10, 2021
07:51AM EDT  Sonnet Bio's Interleukin 12 Candidate For Solid Tumor Shows Encouraging Action Preclinical Studies   Benzinga
06:35AM EDT  Sonnet BioTherapeutics Completes Successful GLP Repeat Dose Toxicology Study of IL12-FHAB in Non-Human Primates   Benzinga
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
May 3, 2021
03:50PM EDT  Sonnet BioTherapeutics shares were trading higher after the company announced it completed a licensing agreement with New Life Therapeutics.   Benzinga
06:05AM EDT  Sonnet BioTherapeutics Completes Licensing Agreement with New Life Therapeutics; Sonnet To Receive $1M Upfront And Is Eligible To Receive Up To $20M In Milestone Payments   Benzinga
Mar 29, 2021
04:32PM EDT  Sonnet BioTherapeutics Provides 2021 Business Update   Benzinga
Feb 16, 2021
08:14AM EST  Sonnet BioTherapeutics Q1 EPS $(0.34) Up From $(0.44) YoY   Benzinga
Feb 3, 2021
06:38AM EST  Sonnet BioTherapeutics Announces Abstract Accepted for Presentation at AACR 2021 Annual Meeting   Benzinga
Feb 1, 2021
06:33AM EST  Sonnet BioTherapeutics Completes a Non-Human Study of Repeat Dose SON-1010   Benzinga
Jan 25, 2021
06:36AM EST  Sonnet BioTherapeutics Says it Successfully Completed a Non-Human Study of SON-080, Expects to Submit Investigational New Drug Application in 2H 2021   Benzinga
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Dec 17, 2020
08:55AM EST  Sonnet BioTherapeutics Files For Mixed Shelf Of Up To $100M   Benzinga
06:34AM EST  Sonnet BioTherapeutics Q3 EPS $(6.96) Down From $(0.91) YoY   Benzinga
Nov 30, 2020
08:50AM EST  Sonnet BioTherapeutics Announces Completion Of Successful Non-Human Primate Study Of SON-1010   Benzinga
Sep 4, 2020
04:50AM EDT  Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Raises Price Target to $8   Benzinga
Sep 1, 2020
08:39AM EDT  Sonnet Announces New Preclinical Data For SON-1010 (Interleukin 12-F(H)AB)   Benzinga
Aug 25, 2020
02:30PM EDT  Mid-Afternoon Market Update: Crude Oil Rises 2%; Children's Place Shares Plunge On Wider-Than-Expected Q2 Loss   Benzinga
12:00PM EDT  Mid-Day Market Update: Dow Tumbles 170 Points; Viveve Medical Shares Spike Higher   Benzinga
11:59AM EDT  Mid-Morning Market Update: Markets Mostly Lower; Hormel Foods Earnings Top Views   Benzinga
Aug 24, 2020
02:51PM EDT  Mid-Afternoon Market Update: MOGU Falls After Q1 Results; Cancer Genetics Shares Jump   Benzinga
12:01PM EDT  Mid-Day Market Update: Dow Rises 1%; Sonnet BioTherapeutics Shares Spike Higher   Benzinga
10:20AM EDT  Mid-Morning Market Update: Markets Open Higher; FDA Issues Emergency Use Authorization For Convalescent Plasma To Treat Coronavirus   Benzinga
10:12AM EDT  Shares of Sonnet BioTherapeutics Holdings Inc. (SONN) are gaining almost 41 percent or $1.08 in Monday's morning trade at $3.71.   RTTNews
09:20AM EDT  'Dr. Scott Gottlieb: Coronavirus plasma treatment might help but 'doesn't look like a home run' -CNBC Tweet   Benzinga
08:32AM EDT  From Benzinga's PreMarket Prep: Co-Host Dennis Dick Says If He Was In Plasma Stocks Right Now He Would Sell Them; Notes 'This Is A Gift I Would Ring The Register Right Now'   Benzinga
Aug 14, 2020
07:39AM EDT  Sonnet BioTherapeutics Q2 EPS $(1.05) Down From $(0.26) YoY   Benzinga
Aug 4, 2020
07:37AM EDT  Sonnet BioTherapeutics Announces At-The-Market Warrant Repricing And Exchange Resulting In Expected Gross Proceeds To The Company Of Up To $10.5M   Benzinga
07:36AM EDT  Sonnet BioTherapeutics Signs Letter Of Intent For Potential Licensing Of Neuropathies Asset To New Life Therapeutics; Co. To Receive $500K Payment At Signing And Up To $40M In Milestones And 30% Royalty On Commercial Sales   Benzinga
Jul 31, 2020
12:40PM EDT  Mid-Day Market Update: Gold Surges 2.5%; Tiziana Life Sciences Shares Spike Higher   Benzinga
10:13AM EDT  Mid-Morning Market Update: Markets Mixed; Apple Beats Q3 Expectations   Benzinga
10:11AM EDT  Stock Alert: Sonnet BioTherapeutics Soars 145%   RTTNews
Jul 20, 2020
07:39AM EDT  Sonnet Biotherapeutics Announces Preclinical Results From Initial Efficacy Study Exploring Combination Of Granulocyte-Macrophage Colony-Stimulating Factor With Interleukins 18 And 12   Benzinga
Jul 15, 2020
04:49AM EDT  55 Biggest Movers From Yesterday   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC